Home Heart Health Popular cholesterol drug may raise kidney risks

Popular cholesterol drug may raise kidney risks

Credit: Unsplash+

Millions of people around the world take cholesterol-lowering medicines every day to protect themselves from heart disease and stroke.

These drugs, known as statins, are among the most commonly prescribed medicines because they help lower harmful cholesterol levels in the blood. For many people, statins can greatly reduce the risk of heart attacks and other serious cardiovascular problems.

However, a new study has raised concerns about one widely used statin medicine called rosuvastatin. Researchers found that while the drug is effective at lowering cholesterol, it may also increase the risk of certain kidney problems, especially when taken at higher doses.

The study was published in the Journal of the American Society of Nephrology. Researchers wanted to compare the kidney safety of rosuvastatin with another popular statin drug called atorvastatin.

Both medicines are used to lower cholesterol and reduce the buildup of fatty material inside blood vessels. When cholesterol levels stay too high, blood vessels can become narrow or blocked, increasing the risk of heart attacks, strokes, and other dangerous health conditions.

Statins work by reducing the amount of cholesterol the liver produces. Doctors often prescribe them to people with high cholesterol, diabetes, heart disease, or other conditions that increase cardiovascular risk.

Although statins are considered highly effective, scientists continue to study their possible side effects because so many people rely on these medicines for long-term treatment.

To better understand how rosuvastatin and atorvastatin affect the kidneys, the researchers reviewed medical records from more than 900,000 people who had started taking one of the two drugs. This made the study one of the largest investigations of its kind.

The researchers followed these patients over time and looked for signs of kidney-related problems. The results showed that people taking rosuvastatin were more likely to develop several kidney issues compared with people taking atorvastatin.

One problem was blood in the urine, which doctors call hematuria. Another was protein in the urine, known as proteinuria. Normally, urine should contain little or no protein. When protein appears in the urine, it may be a sign that the kidneys are not filtering waste properly.

The study also found that, in more severe cases, some people taking rosuvastatin were more likely to require kidney replacement therapy, such as dialysis. Dialysis is a treatment used when the kidneys can no longer effectively clean waste and extra fluid from the blood.

The researchers noticed another important pattern. Higher doses of rosuvastatin appeared to increase the risk of kidney problems even more. In simple terms, the stronger the dose, the greater the risk seemed to be. Atorvastatin, in comparison, appeared to have a lower risk of causing kidney-related side effects.

The findings are important because many people who take statins are older adults or people already dealing with other health problems. Some patients may already have mild kidney disease, diabetes, or high blood pressure, all of which can place extra stress on the kidneys.

The kidneys are vital organs that help remove waste, balance fluids, control blood pressure, and keep the body healthy. When kidney function declines, waste products can build up in the blood, leading to fatigue, swelling, nausea, and other serious health problems.

Even though the study found a link between rosuvastatin and kidney problems, the researchers did not suggest that everyone should stop taking the medicine. Statins still provide major benefits for many patients, especially those at high risk of heart disease.

Instead, the researchers emphasized that doctors and patients should carefully consider both the benefits and risks when choosing the best cholesterol medicine.

People who already have kidney disease or other kidney risk factors may especially benefit from discussing this research with their doctor. In some cases, another cholesterol-lowering medicine may be more suitable.

The study also highlights the importance of regular medical check-ups. Doctors can monitor kidney health using urine tests and blood tests to look for early warning signs of kidney damage. Finding problems early may help prevent more serious complications later.

Patients taking rosuvastatin should pay attention to any unusual symptoms and speak with a healthcare professional if they notice changes in their urine, swelling in the legs or feet, tiredness, or pain in the lower back area.

Experts also remind people that medicines are only one part of protecting heart and kidney health. Healthy lifestyle habits can make a big difference as well.

Eating a balanced diet, exercising regularly, avoiding smoking, controlling blood pressure, and maintaining a healthy weight all help lower cholesterol and support kidney function.

This study is another reminder that medical treatments often involve balancing benefits and risks.

While rosuvastatin may help protect the heart, doctors and patients should also pay attention to possible effects on the kidneys. Careful monitoring and personalized treatment decisions can help people stay healthier in the long term.

If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce risk of kidney injury.

For more health information, please see recent studies about foods that may prevent recurrence of kidney stones, and eating nuts linked to lower risk of chronic kidney disease and death.

Copyright © 2026 Knowridge Science Report. All rights reserved.